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Abstract Oxidative stress and the generation of reactive
oxygen species (ROS) have been implicated in the pathogenesis
of cellular damage. These events have usually been reported in
terms of oxidation of a reporter molecule such as 2P,7P-
dichlorodihydrofluorescin diacetate (DCFH-DA). Treatment of
HeLa cells with hemin or metalloporphyrins resulted in a rapid
oxidation of DCFH in a time- and dose-dependent manner. This
oxidation was inhibited by treatment of the cells with a large
amount of superoxide dismutase and catalase, which is different
from observations that these enzymes had no effect on the
induction of heme oxygenase-1, a stress-induced protein, in
hemin-treated cells. To examine the possibility that the oxidation
of DCFH is independent of the generation of ROS, the oxidation
was measured using hemoglobin-synthesizing erythroleukemia
K562 cells. When K562 cells were treated with N-aminolevulinic
acid, a precursor of heme, oxidation of DCFH increased
depending on the heme content in cells. Then DCFH-DA was
oxidized directly with heme, hemoglobin, myoglobin and
cytochrome c. These results suggest that oxidation of DCFH is
not always related to the generation of ROS but may be related
to heme content in cells. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.




2P,7P-Dichlorodihydro£uorescin (DCFH) is widely used to
measure oxidative stress in cells. The diacetate ester form of
DCFH, 2P,7P-dichlorodihydro£uorescin diacetate (DCFH-
DA), is relatively resistant to oxidation, but when taken up
by cells, is de-acetylated to form DCFH, which then forms a
two-electron oxidation product, the highly £uorescent com-
pound dichloro£uorescin (DCF), in a reaction with the oxi-
dizing species liberated [1,2]. The oxidant involved is H2O2
[1,2], but in the absence of cellular peroxidase the actual ox-
idant is more likely to be a Fenton-type species rather than
the peroxide [3]. Other oxidizing species include nitric oxide
[4], peroxynitrite [5], hypothiocyanite [6] and peroxyl radical
[7]. Thus, formed reactive oxygen species (ROS) are important
regulators of apoptosis [8].
Heme is the cofactor of proteins involved in a variety of
biological processes such as oxygen transport, oxygenation
and electron transfer. Free heme is a major source of iron
that contributes to the generation of hydroxyl radicals by
the Fenton reaction [9], damaging lipids and proteins, events
which potentiate oxidative damage. Moreover, the generation
of ROS as well as the radical reaction occurs upon injury to
various tissues and red blood cells and the production of
hydroxyl radical from hydrogen peroxide by releasing heme
of hemoglobin and myoglobin follows cell membrane damage
[10]. Since both heme and iron can be involved in the gener-
ation of potentially harmful ROS, the breakdown of heme
and subsequent sequestration of heme iron in ferritin may
be a mechanism of protection of cells from oxidative stress
[11].
Heme oxygenase (HO) is the rate-limiting enzyme in the
cellular catabolism of heme, in which heme is degraded to
biliverdin, carbon monoxide, and ferric ions. Biliverdin is rap-
idly converted to bilirubin by biliverdin reductase. Three iso-
forms of HO have been identi¢ed, the inducible isoform HO-
1, the constitutive isoform HO-2, and a recently characterized
isoform HO-3 with low enzyme activity [10,11]. Expression of
HO-1, a protein also known as heat shock protein 32, is
induced by its substrate heme, but also following exposure
to a variety of stress stimuli, including UV irradiation,
H2O2, NO, heavy metals, phorbol ester, endotoxin and organ-
ic chemicals [11,12]. Interestingly, most of the known HO-1
inducers stimulate the production of ROS or lead to depletion
of glutathione levels, suggesting the involvement of HO-1 ac-
tivity in cellular protection against oxidative stress. However,
any e¡ect of HO-1 on hemin-induced oxidative stress has not
been de¢ned.
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During a study of which heme regulates the transcription of
genes such as the HO-1 and c-fos genes [13,14], we examined
the relationship between the generation of ROS and the ex-
pression of HO-1 induced by hemin and found that the oxi-
dation of DCFH occurred on treatment of the cells with
hemin. In addition, we found that the £uorescence did not
re£ect the generation of ROS but that the probe reacted di-
rectly with heme and hemoproteins. Obstacles to evaluating
the generation of ROS with these chemicals are discussed.
2. Materials and methods
2.1. Materials
[K-32P]dCTP (3000 Ci/mmol) was obtained from NEN. Zinc-, co-
balt-, and tin-protoporphyrins were gifts from Dr. S. Sassa of The
Rockefeller University. DCFH-DA was from Molecular Probes Co.
Dihydrorhodamine 123, N-aminolevulinic acid (ALA), N-acetylcys-
teine, cytochrome c (bovine heart) and hemoglobin (bovine) were
products of Sigma Chemicals Co. Catalase (bovine liver, 6500
U/mg) and superoxide dismutase (SOD; bovine erythrocytes, 5000
U/mg) were purchased from Wako Pure Chemicals Co. Dulbecco’s
modi¢ed Eagle’s medium (DMEM), fetal calf serum (FCS) and RPMI
1640 medium were from Gibco^Invitrogen Co. Hemin and metallo-
porphyrins were dissolved in dimethyl sulfoxide at a concentration of
20 mM, then diluted 20-fold with phosphate-bu¡ered saline (PBS)
containing 10 mg/ml bovine serum albumin (BSA). All other chem-
icals used were of analytical grade.
2.2. Cell culture
HeLa cells were maintained in DMEM supplemented with 10%
FCS, 50 U/ml penicillin, and 50 mg/ml streptomycin. To expose
them to hemin, the cells were washed twice with PBS, placed in
DMEM containing 1 mg/ml BSA, and then incubated in the presence
of 10 WM hemin at 37‡C for a speci¢c period. The cells were incubated
with SOD or catalase at 37‡C for 1 h, followed by hemin. They were
washed twice with PBS after collected. Human erythroleukemia K562
cells were grown in RPMI 1640 medium supplemented with 10% FCS,
50 U/ml penicillin, and 50 mg/ml streptomycin. For di¡erentiation,
the cells were incubated with 100 WM ALA or 25 WM hemin for 48 h.
The heme content of the cells was determined by £uorescence spec-
trophotometry [15].
2.3. Northern blots
Total RNA from the cells was prepared by the guanidium isothio-
cyanate method [14]. The RNA preparations were electrophoresed in
a 1% agarose gel under denaturing conditions, and then transferred
onto a nylon ¢lter. Conditions for hybridization with a radiolabeled
fragment of HO-1 cDNA and washing were as described [13,14].
Fig. 1. Oxidation of DCFH in hemin- and metalloporphyrin-treated HeLa cells. A: HeLa cells (1U105 cells) were incubated with 10 WM hemin
for the periods indicated, followed by 10 WM DCFH-DA for 10 min. The cells were washed and lysed, and the £uorescence of homogenates
was determined. B: The cells were treated with the indicated concentrations of hemin for 60 min. The DCF £uorescence in the cells was mea-
sured as above. C: The cells were pretreated with the indicated amounts of catalase or SOD for 30 min, then incubated with 10 WM hemin for
60 min. After a 10 min incubation with DCFH-DA, cells were collected and washed, and the £uorescence in the cells was measured. D: The
cells were left untreated (lane 1) or treated with 10 WM hemin (lane 2), 10 WM cobalt-protoporphyrin (lane 3), 10 WM tin-protoporphyrin (lane
4) or 10 WM zinc-protoporphyrin (lane 5) for 60 min. The oxidation of DCFH was measured as above. Data are expressed as the mean þ stan-
dard deviation of triplicate experiments.
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2.4. Fluorescence spectrophotometry
Cells were incubated with DCFH-DA (10 WM) at 37‡C for 10 min.
They were then washed twice with PBS, and lysed with 10 mM Tris^
HCl bu¡er, pH 7.4, containing 0.5% Tween 20. The homogenates
were centrifuged at 10 000Ug for 10 min to remove cell debris.
DCF £uorescence in the supernatant was measured using a spectro-
£uorometer with excitation of 500 nm and emission by scanning from
500 to 550 nm [11]. Oxidation of dihydrorhodamine 123 was mea-
sured with excitation at 500 nm and emission at 536 nm. Data were
normalized to values obtained from untreated controls.
2.5. Microscopy
The localization of the £uorescence in cells treated with DCFH-DA
was examined, using a Carl Zeiss LSM 510 confocal microscope. Cells
incubated with DCFH-DA were washed twice with PBS and living
cells were observed.
3. Results
3.1. Oxidation of DCFH-DA and dihydrorhodamine 123 in
hemin-treated HeLa cells
To explore the possibility that treatment with hemin results
in the generation of ROS, HeLa cells were incubated with 10
WM hemin for a given period, and the generation of ROS was
evaluated on addition of DCFH-DA at 37‡C for 10 min. The
£uorescence with emission peaked at about 525 nm rapidly
appeared in a time- and dose-dependent manner (Fig. 1A,B).
To clarify the mechanisms by which exogenously added hemin
generates superoxide or hydrogen peroxide, which is able to
promote the oxidation of DCFH, cells were pretreated with
ROS-metabolizing enzymes including catalase and SOD, fol-
lowed by incubation with hemin. The pretreatment of the cells
with a high concentration of SOD decreased the £uorescence,
and catalase partly inhibited this e¡ect (Fig. 1C). Antioxidants
N-acetylcysteine (2 mM), pyrrolidine dithiocarbamate (100
WM) and bilirubin (10 WM) were without e¡ect. When co-
balt-protoporphyrin (10 WM), which is a potent inducer of
HO-1 [10,14], was incubated with the cells, the oxidation of
DCFH also occurred, but to a lesser extent (Fig. 1D). Even
tin-protoporphyrin (10 WM) and zinc-protoporphyrin (10
WM), inhibitors of HO-1 [10,16,17], caused the oxidation.
We further examined the localization of the £uorescence in
cells by confocal microscopy. Intense DCFH-derived £uores-
cence was found in whole cells treated with 10 WM hemin or
10 WM cobalt-protoporphyrin (Fig. 2B,D), while pretreatment
of the cells with SOD led to a diminishment of the £uores-
cence (Fig. 2C). We then examined the oxidation of dihydro-
rhodamine 123, another marker of ROS generation, in hemin-
treated HeLa cells (Fig. 3). The £uorescence in the cells also
markedly increased on treatment with hemin, similar to the
case with DCFH.
Since treatment with SOD resulted in a decrease of the
hemin-dependent oxidation of DCFH, we next examined the
e¡ect of SOD on the induction of HO-1 mRNA in hemin-
treated HeLa cells. As shown in Fig. 4, treatment of cells with
10 WM hemin for 2 h resulted in the induction of HO-1
Fig. 2. Microscopic observation of DCF £uorescence in hemin- and cobalt-protoporphyrin-treated HeLa cells. Cells were incubated alone (A) or
with hemin (B) and cobalt-protoporphyrin (C), followed by DCFH-DA, under conditions similar to those outlined in the legend of Fig. 1D.
Cells were also incubated with 10 WM hemin plus 2.5 mg/ml SOD (D), as above, washed twice with PBS, and then visualized by confocal
microscopy.
Fig. 3. Oxidation of dihydrorhodamine in hemin-treated HeLa cells.
Cells were incubated with 10 WM hemin for the period indicated,
and then with 10 WM dihydrorhodamine for 10 min. They were
then collected, washed twice with PBS, and lysed. The £uorescence
in the cells was measured as described in Section 2. Bars represent
standard deviation (n = 3).
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mRNA, and the hemin-dependent induction did not change
on treatment with SOD or catalase. These results indicated
that the oxidation of DCFH is not paralleled by the expres-
sion of HO-1 mRNA induced by hemin.
3.2. Oxidation of DCFH is not re£ected by ROS generation
but associated with heme content in
hemoglobin-synthesizing K562 cells
It is possible that heme and not ROS causes the direct
oxidation of DCFH. We then examined the oxidation of
DCFH in human erythroleukemia K562 cells which are capa-
ble of the biosynthesis of hemoglobin. When K562 cells were
cultured in the presence of 50 WM ALA, a precursor of heme,
for 48 h, the heme content of cells increased 20-fold compared
to the control (Fig. 5). Then, using the ALA-treated cells, the
oxidation of DCFH was compared with that in control cells.
The DCF £uorescence in ALA-treated cells was ¢ve-fold that
in the control. On incubation with 100 WM ALA, the £uores-
cence was higher than that in 50 WM ALA-treated cells. In-
cubation of K562 cells with hemin for 48 h led to an increase
in the DCF £uorescence, and the extent of the £uorescence
depended on the content of the intracellular heme (Fig. 5).
Strong £uorescence was observed in hemoglobin-synthesizing
K562 cells, and the intensity of the DCF £uorescence in he-
min-treated cells was similar to that in ALA-treated cells.
These results suggest that the formation of DCF £uorescence
does not always depend on the generation of ROS but can be
attributed to the heme content of the cells.
3.3. Heme, hemoglobin, myoglobin and cytochrome c oxidize
DCFH-DA in vitro
Finally, we examined if heme in the reduced or oxidized
form can directly oxidize DCFH-DA, since the oxidation of
DCFH occurred in frozen K562 cells after thawing when in-
cubated with hemin^albumin. Then, we tried to perform ex-
periments without cells. The hemin^albumin complex was
treated with sodium hydrosul¢te to reduce heme. A reduced
form of the complex was obtained by gel ¢ltration, and im-
mediately incubated with DCFH-DA at 37‡C for a speci¢c
period. As shown in Fig. 6, the oxidation of DCFH occurred
with reduced heme in a time-dependent manner. Reduced
forms of hemoglobin, myoglobin and cytochrome c also
caused a rapid oxidation of DCFH. Oxidized [Fe(III)] forms
of heme (hemin), hemoglobin and myoglobin oxidized DCFH
as well, but to much lesser extent than the reduced hemopro-
teins. On incubation of the oxidized form of cytochrome c
with DCFH-DA, no £uorescence was observed. Thus, the
oxidation of DCFH occurs directly with heme and hemopro-
teins.
4. Discussion
The present study demonstrates that DCFH, a probe used
to measure the generation of ROS, is directly oxidized to
DCF by heme and hemoproteins. Another chemical, dihydro-
rhodamine, also reacts with heme. Treatment of cells with
metalloporphyrins including cobalt-, tin-, and zinc-protopor-
phyrin caused the oxidation of DCFH. Of the compounds
tested, only SOD and catalase inhibited the heme-dependent
oxidation of DCFH. These observations were similar to those
by Rota et al. [18] who found that the oxidation of DCFH to
DCF occurred with horseradish peroxidase (HRP) in the pres-
ence or absence of the substrate H2O2. The level of HRP-
dependent DCF £uorescence was higher with than that with-
out H2O2. Reduction of HRP^heme by H2O2 [18] supports
our in vitro observation that reduced hemoproteins oxidize
DCFH much better than do oxidized hemoproteins. Similarly,
Burkitt and Wardman [19] reported that cytochrome c is a
potent catalyst of DCFH oxidation and claimed that DCF
£uorescence in pre-apoptotic and apoptotic cells is a measure
of cytosolic cytochrome c rather than superoxide and H2O2.
Since the extent of oxidation of DCFH with reduced heme
was unexpectedly much higher than that with oxidized heme,
the reaction mechanisms in the two cases may be di¡erent. As
DCFH is a highly reactive reductant, hemin and the oxidized
form of hemoglobin or myoglobin were reduced with a con-
comitant oxidation of DCFH-DA. On the other hand, the
reduced heme reacts with DCFH in the presence of oxygen
to cause a more e¡ective oxidation of DCFH, although the
mechanism involved such as the formation of a ternary com-
plex of heme, oxygen and DCFH remains unexplored.
There are several controversies in studies concerning the
e¡ect of the addition of SOD on oxidative stress in cells as
monitored with DCFH. Some studies reported an inhibitory
e¡ect by SOD [20^22], whereas almost the same number of
studies reported that SOD had no e¡ect [23^25]. The ¢nding
made here, that SOD inhibited the oxidation of DCFH, could
provide an explanation for discrepancies regarding the e¡ect
of SOD on the DCFH test for oxidative stress. Namely, it is
possible that the amount of ROS was overestimated using
heme or hemoproteins in cells in some cases.
Fig. 4. RNA blots of HO-1 in hemin-treated HeLa cells. A: Total
RNA (10 Wg) from cells left untreated (lane 1) or treated with 10
WM hemin (lane 2), 10 WM hemin+2.5 mg/ml SOD (lane 3), 10 WM
hemin+2.5 mg/ml catalase (lane 4), 10 WM hemin+2.5 mg/ml
SOD+2.5 mg/ml catalase (lane 5) or 2.5 mg/ml SOD+2.5 mg/ml cat-
alase (lane 6) for 2 h was electrophoresed, transferred onto ¢lters,
and hybridized with cDNA fragments of human HO-1 (upper panel)
and L-actin (lower panel). An arrow shows the position of HO-1
mRNA. B: Densitometric quantitation of HO-1 mRNA. The lanes
shown are the same as above. Values are expressed as the mean þ
standard deviation of triplicate experiments.
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Metalloporphyrins are highly reactive molecules and e¡ec-
tively mediate destruction of macromolecules through the gen-
eration of ROS, leading to apoptosis [10]. The ¢nding that
treatment of cells with metalloporphyrins including cobalt-,
zinc- and tin-protoporphyrin caused oxidation of DCFH
can be related to the generation of ROS in cells, but this
possibility was ruled out by observations that these metallo-
porphyrins also oxidize DCFH in vitro. Furthermore, the
oxidation of DCFH is not related to the induction of HO-1
by metalloporphyrins since cobalt-protoporphyrin is an po-
tent inducer of HO-1, but tin- and zinc-protoporphyrin are
inhibitors. Metalloporphyrins are capable of binding to oxy-
gen [26], suggesting that metalloporphyrins are potent cata-
lysts of the oxidation of reactive DCFH. It is unclear, how-
ever, whether the mechanisms involved in the oxidation of
DCFH by metalloporphyrins and by hemin are the same.
Heme is an oxidant in several model systems [11,27]. The
present study showed that hemin-dependent induction of HO-
1 mRNA expression was not a¡ected by treatment with ROS-
modifying enzymes such as SOD and catalase which detoxify
the mediators of oxidative stress (Fig. 4). The binding sites of
many transcriptional factors have been identi¢ed in the pro-
moter region of the HO-1 gene, and Nrf2 is found to be a
major factor in the response to heavy metals and oxidative
Fig. 5. Oxidation of DCFH in human erythroleukemia K562 cells induced to di¡erentiate by treatment with ALA and hemin. A: K562 cells
were left untreated (lane 1) or treated with 25 WM (lane 2) or 50 WM hemin (lane 3), and incubated with 50 WM (lane 4) or 100 WM ALA
(lane 5) for 48 h. The amount of DCF £uorescence and heme in the cells was determined by £uorescence spectrophotometry. Bars represent
the standard deviation (n = 3). B: Confocal microscopic observations. Untreated K562 cells (top); 50 WM hemin-treated K562 cells (center)
and; 100 WM ALA-treated K562 cells (bottom).
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stress [28]. In response to hemin treatment, an increase in the
binding of a number of transcriptional factors has been
demonstrated, most signi¢cantly, AP-2 and NF-UB [11]. We
previously showed that a rapid and transient activation of
the AP-1 transcriptional complex occurred in hemin-treated
HeLa cells, without translocation and activation of NF-UB
[14]. The mechanisms involved in the induction of HO-1
mRNA expression by hemin treatment have yet to be estab-
lished.
K562 cells undergo erythroid di¡erentiation on treatment
with hemin and anti-tumor drugs including aclarubicin and
doxorubicin [29]. The treatment of K562 cells with hemin
induced stress-related cellular modi¢cations such as an in-
crease in heat shock protein and thioredoxin expression [30].
During these treatments, the cells generate ROS which regu-
late cell growth, indicating that oxygen stress can be essential
for the di¡erentiation process [31]. In addition, human mye-
loleukemic HL60 cells were used to study NADPH oxidase-
generating superoxide or chemically induced apoptosis [32,33].
Neutrophils were also employed as a model of superoxide
production by NADPH oxidase [34]. In these studies,
DCFH has proved a good marker for measuring ROS. How-
ever, these cells contain a large amount of hemoproteins in-
cluding myeloperoxidase and hemoglobin [29,35,36]. Based on
our observation that heme oxidizes DCFH directly, it is pos-
sible that changes in the level of cellular hemoproteins lead to
an inaccurate estimation of the amount of ROS in cells by
measuring oxidation of DCFH. Alternatively, measuring the
oxidation of DCFH is a sensitive method to estimate the heme
content of cells.
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